Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2007, Article ID 51837, 10 pages
http://dx.doi.org/10.1155/2007/51837
Research Article

Inhibition of Advanced Glycation and Absence of Galectin-3 Prevent Blood-Retinal Barrier Dysfunction during Short-Term Diabetes

1Centre for Vision Science, Queen's University Belfast, Royal Victoria Hospital, Grosvenor Road, Belfast, Northern Ireland BT12 6BA, UK
2Department of Dermatology, School of Medicine, University of California, Sacramento, CA 95616, USA

Received 22 December 2006; Accepted 2 February 2007

Academic Editor: Subrata Chakrabarti

Copyright © 2007 Paul Canning et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [49 citations]

The following is the list of published articles that have cited the current article.

  • Mingyuan Wu, Ying Chen, Kenneth Wilson, Alin Chirindel, Michael A. Ihnat, Yongxin Yu, Michael E. Boulton, Luke I. Szweda, Jian-Xing Ma, and Timothy J. Lyons, “Intraretinal leakage and oxidation of LDL in diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 49, no. 6, pp. 2679–2685, 2008. View at Publisher · View at Google Scholar
  • Bhatwadekar, Glenn, Figarola, Scott, Gardiner, Rahbar, and Stitt, “A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats,” British Journal of Ophthalmology, vol. 92, no. 4, pp. 545–547, 2008. View at Publisher · View at Google Scholar
  • Ashay D. Bhatwadekar, Josephine V. Glenn, Gang Li, Tim M. Curtis, Tom A. Gardiner, and Alan W. Stitt, “Advanced glycation of fibronectin impairs vascular repair by endothelial progenitor cells: Implications for vasodegeneration in diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 49, no. 3, pp. 1232–1241, 2008. View at Publisher · View at Google Scholar
  • Jennifer L. Wilkinson-Berka, and Antonia G. Miller, “Update on the treatment of diabetic retinopathy,” TheScientificWorldJournal, vol. 8, pp. 98–120, 2008. View at Publisher · View at Google Scholar
  • Dinesh Thotala, Sergei Chetyrkin, Billy Hudson, Dennis Hallahan, Paul Voziyan, and Eugenia Yazlovitskaya, “Pyridoxamine protects intestinal epithelium from ionizing radiation-induced apoptosis,” Free Radical Biology And Medicine, vol. 47, no. 6, pp. 779–785, 2009. View at Publisher · View at Google Scholar
  • T. M. Curtis, T. A. Gardiner, and A. W. Stitt, “Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis?,” Eye, vol. 23, no. 7, pp. 1496–1508, 2009. View at Publisher · View at Google Scholar
  • Lucy V. Norling, Mauro Perretti, and Dianne Cooper, “Endogenous galectins and the control of the host inflammatory response,” Journal of Endocrinology, vol. 201, no. 2, pp. 169–184, 2009. View at Publisher · View at Google Scholar
  • Douglas J. Rhee, Ramez I. Haddadin, Min Hyung Kang, and Dong-Jin Oh, “Matricellular proteins in the trabecular meshwork,” Experimental Eye Research, vol. 88, no. 4, pp. 694–703, 2009. View at Publisher · View at Google Scholar
  • Willard M. Freeman, Georgina V. Bixler, Robert M. Brucklacher, Erin Walsh, Scot R. Kimball, Leonard S. Jefferson, and Sarah K. Bronson, “Transcriptomic comparison of the retina in two mouse models of diabetes,” Journal of Ocular Biology, Diseases, and Informatics, vol. 2, no. 4, pp. 202–213, 2009. View at Publisher · View at Google Scholar
  • Josephine V. Glenn, and Alan W. Stitt, “The role of advanced glycation end products in retinal ageing and disease,” Biochimica et Biophysica Acta-General Subjects, vol. 1790, no. 10, pp. 1109–1116, 2009. View at Publisher · View at Google Scholar
  • Permal Deo, Josephine V. Glenn, Lesley A. Powell, Alan W. Stitt, and Jennifer M. Ames, “Upregulation of Oxidative Stress Markers in Human Microvascular Endothelial Cells by Complexes of Serum Albumin and Digestion Products of Glycated Casein,” Journal Of Biochemical And Molecular Toxicology, vol. 23, no. 5, pp. 364–372, 2009. View at Publisher · View at Google Scholar
  • Alan W. Stitt, “AGEs and Diabetic Retinopathy,” Investigative Ophthalmology & Visual Science, vol. 51, no. 10, pp. 4867–4874, 2010. View at Publisher · View at Google Scholar
  • Hongliang Zong, Micheal Ward, and Alan W. Stitt, “AGEs, RAGE, and Diabetic Retinopathy,” Current Diabetes Reports, vol. 11, no. 4, pp. 244–252, 2011. View at Publisher · View at Google Scholar
  • F. Shimizu, Y. Sano, H. Haruki, and T. Kanda, “Advanced glycation end-products induce basement membrane hypertrophy in endoneurial microvessels and disrupt the blood-nerve barrier by stimulating the release of TGF-beta and vascular endothelial growth factor (VEGF) by pericytes,” Diabetologia, vol. 54, no. 6, pp. 1517–1526, 2011. View at Publisher · View at Google Scholar
  • Alan W. Stitt, and Timothy M. Curtis, “Diabetes-related adduct formation and retinopathy,” Journal of Ocular Biology, Diseases, and Informatics, vol. 4, no. 1-2, pp. 10–18, 2011. View at Publisher · View at Google Scholar
  • T. M. Curtis, R. Hamilton, P. -H. Yong, C. M. McVicar, A. Berner, R. Pringle, K. Uchida, R. Nagai, S. Brockbank, and A. W. Stitt, “Muller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products,” Diabetologia, vol. 54, no. 3, pp. 690–698, 2011. View at Publisher · View at Google Scholar
  • A. K. Berner, O. Brouwers, R. Pringle, I. Klaassen, L. Colhoun, C. McVicar, S. Brockbank, J. W. Curry, T. Miyata, M. Brownlee, R. O. Schlingemann, C. Schalkwijk, and A. W. Stitt, “Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology,” Diabetologia, vol. 55, no. 3, pp. 845–854, 2011. View at Publisher · View at Google Scholar
  • Heather D. VanGuilder, Georgina V. Bixler, Lydia Kutzler, Robert M. Brucklacher, Sarah K. Bronson, Scot R. Kimball, and Willard M. Freeman, “Multi-Modal Proteomic Analysis of Retinal Protein Expression Alterations in a Rat Model of Diabetic Retinopathy,” Plos One, vol. 6, no. 1, 2011. View at Publisher · View at Google Scholar
  • Ursula Schloetzer-Schrehardt, Sabine Andre, Christina Janko, Herbert Kaltner, Juergen Kopitz, Hans-Joachim Gabius, and Martin Herrmann, “Adhesion/growth-regulatory galectins in the human eye: localization profiles and tissue reactivities as a standard to detect disease-associated alterations,” Graefes Archive For Clinical And Experimental Ophthalmology, vol. 250, no. 8, pp. 1169–1180, 2012. View at Publisher · View at Google Scholar
  • Mingyuan Wu, Shihe Yang, Michael H. Elliott, Dongxu Fu, Kenneth Wilson, Jing Zhang, Mei Du, Junping Chen, and Timothy Lyons, “Oxidative and endoplasmic reticulum stresses mediate apoptosis induced by modified LDL in human retinal Müller cells,” Investigative Ophthalmology and Visual Science, vol. 53, no. 8, pp. 4595–4604, 2012. View at Publisher · View at Google Scholar
  • Daniel K. Hsu, Ri-Yao Yang, Agnes Fermin, and Fu-Tong Liu, “Galectins in Immune and Inflammatory Diseases: Insights from Experiments with Galectin Deficient Mice,” Galectins and Disease Implications for Targeted Therapeutics, vol. 1115, pp. 343–358, 2012. View at Publisher · View at Google Scholar
  • In Hwan Hong, Hyeong Gon Yu, and Sung Pyo Park, “Suppression of VEGF and Decrease in Vascular Leakage by Pyridoxal 5'-Phosphate in Diabetic Rats,” Journal of the Korean Ophthalmological Society, vol. 53, no. 5, pp. 700, 2012. View at Publisher · View at Google Scholar
  • Chen, Curtis, and Stitt, “Advanced glycation end products and diabetic retinopathy,” Current Medicinal Chemistry, vol. 20, no. 26, pp. 3234–3240, 2013. View at Publisher · View at Google Scholar
  • Qin Shen, Jim Wu, and Jason C. Wong, “Potential drug interventions for diabetic retinopathy,” Drug Discovery Today, 2013. View at Publisher · View at Google Scholar
  • Mohamed M. Elseweidy, Sahar E. Elswefy, Nahla N. Younis, and Mohamed S. Zaghloul, “Pyridoxamine, an inhibitor of protein glycation, in relation to microalbuminuria and proinflammatory cytokines in experimental diabetic nephropathy,” Experimental Biology and Medicine, vol. 238, no. 8, pp. 881–888, 2013. View at Publisher · View at Google Scholar
  • Qi-Hui Jin, Yu-Feng Lou, Tian-Lang Li, Huai-Hong Chen, Qiang Liu, and Xiao-Jun He, “Serum galectin-3: A risk factor for vascular complications in type 2 diabetes mellitus,” Chinese Medical Journal, vol. 126, no. 11, pp. 2109–2115, 2013. View at Publisher · View at Google Scholar
  • Chee Wai Wong, Tien Yin Wong, Ching-Yu Cheng, and Charumathi Sabanayagam, “Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways,” Kidney International, vol. 85, no. 6, pp. 1290–1302, 2013. View at Publisher · View at Google Scholar
  • A. I. Markowska, Z. Cao, and N. Panjwani, “Glycobiology of ocular angiogenesis,” Glycobiology, 2014. View at Publisher · View at Google Scholar
  • Stylianos A. Kandarakis, Christina Piperi, Fotis Topouzis, and Athanasios G. Papavassiliou, “Emerging role of Advanced Glycation-End Products (AGEs) in the pathobiology of eye diseases,” Progress in Retinal and Eye Research, 2014. View at Publisher · View at Google Scholar
  • Ayan Chatterjee, Guadalupe Villarreal, and Douglas J. Rhee, “Matricellular Proteins in the Trabecular Meshwork: Review and Update,” Journal of Ocular Pharmacology and Therapeutics, pp. 140605085332007, 2014. View at Publisher · View at Google Scholar
  • Kyeojin Kim, Sony Maharjan, Changjin Lim, Nam-Jung Kim, Vijayendra Agrawal, Young Taek Han, Sujin Lee, Hongchan An, Hwayoung Yun, Hyun-Jung Choi, Young-Guen Kwon, and Young-Ger Suh, “Glucal-conjugated sterols as novel vascular leakage blocker: Structure-activity relationship focusing on the C-17-side chain,” European Journal of Medicinal Chemistry, vol. 75, pp. 184–194, 2014. View at Publisher · View at Google Scholar
  • Gustavo Ortiz, Juan P. Salica, Eduardo H. Chuluyan, and Juan E. Gallo, “Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?,” Biological Research, vol. 47, 2014. View at Publisher · View at Google Scholar
  • Giuseppe Pugliese, Carla Iacobini, Carlo Ricci, Claudia Blasetti Fantauzzi, and Stefano Menini, “Galectin-3 in diabetic patients,” Clinical Chemistry and Laboratory Medicine, vol. 52, no. 10, pp. 1413–1423, 2014. View at Publisher · View at Google Scholar
  • G. Pugliese, C. Iacobini, C. M. Pesce, and S. Menini, “Galectin-3: an emerging all-out player in metabolic disorders and their complications,” Glycobiology, 2014. View at Publisher · View at Google Scholar
  • Derya Ozturk, Omer Celik, Seckin Satilmis, Serkan Aslan, Mehmet Erturk, Huseyin Altug Cakmak, Ali Kemal Kalkan, Sinem Ozyilmaz, Vesile Diker, and Mehmet Gul, “Association between serum galectin-3 levels and coronary atherosclerosis and plaque burden/structure in patients with type 2 diabetes mellitus,” Coronary Artery Disease, vol. 26, no. 5, pp. 396–401, 2015. View at Publisher · View at Google Scholar
  • Oscar Manouchehrian, Karin Arnér, Tomas Deierborg, and Linnéa Taylor, “Who let the dogs out?: detrimental role of Galectin-3 in hypoperfusion-induced retinal degeneration,” Journal of Neuroinflammation, vol. 12, no. 1, 2015. View at Publisher · View at Google Scholar
  • Ingeborg Klaassen, Rob J. van Geest, Esther J. Kuiper, Cornelis J.F. van Noorden, and Reinier O. Schlingemann, “The role of CTGF in diabetic retinopathy,” Experimental Eye Research, vol. 133, pp. 37–48, 2015. View at Publisher · View at Google Scholar
  • Leilei Wang, Ning Wang, Horyue Tan, Yinjian Zhang, and Yibin Feng, “Protective Effect of a Chinese Medicine Formula He-Ying-Qing-Re Formula on Diabetic Retinopathy,” Journal of Ethnopharmacology, 2015. View at Publisher · View at Google Scholar
  • Masami Tsukamoto, Kazunori S Sango, Naoko Niimi, Hiroko Yanagisawa, Kazuhiko Watabe, and Kazunori Utsunomiya, “Upregulation of galectin-3 in immortalized Schwann cells IFRS1 under diabetic conditions,” Neuroscience Research, vol. 92, pp. 80–85, 2015. View at Publisher · View at Google Scholar
  • Stefano Fogli, Selene Mogavero, Colin Gerard Egan, Marzia Del Re, and Romano Danesi, “Pathophysiology and pharmacological targets of VEGF in diabetic macular edema,” Pharmacological Research, 2015. View at Publisher · View at Google Scholar
  • Patrik Maximilian Bauer, Marina Castro Zalis, Hodan Abdshill, Tomas Deierborg, Fredrik Johansson, and Ulrica Englund-Johansson, “Inflamed In Vitro Retina: Cytotoxic Neuroinflammation and Galectin-3 Expression,” Plos One, vol. 11, no. 9, pp. e0161723, 2016. View at Publisher · View at Google Scholar
  • Jeremy Y. Yu, Shihe Yang, Michelle B. Hookham, Rebecca McLeese, Dongxu Fu, Anna R. Connell, and Timothy J. Lyons, “Beneficial effects of berberine on oxidized LDL-induced cytotoxicity to human retinal müller cells,” Investigative Ophthalmology and Visual Science, vol. 57, no. 7, pp. 3369–3379, 2016. View at Publisher · View at Google Scholar
  • Jian Li, Wei Cai, Wei Zhang, Wei-Feng Zhu, Ying Liu, Li-Xia Yue, Ling-Yan Zhu, Jun-Ren Xiao, Jian-Ying Liu, and Ji-Xiong Xu, “Polymorphism 2184A/G in the AGER gene is not associated with diabetic retinopathy in Han Chinese patients with type 2 diabetes,” Journal Of International Medical Research, vol. 44, no. 3, pp. 520–528, 2016. View at Publisher · View at Google Scholar
  • Chee Wai Wong, Ecosse Lamoureux, Ching-Yu Cheng, Gemmy Cheung Chui Ming, E. Shyong Tai, Tien Y. Wong, and Charumathi Sabanayagam, “Increased Burden of Vision Impairment and Eye Diseases in Persons with Chronic Kidney Disease — A Population-Based Study,” EBioMedicine, 2016. View at Publisher · View at Google Scholar
  • Thiago Cabral, Luiz Guilherme M. Mello, Luiz H. Lima, Júlia Polido, Caio V. Regatieri, Rubens Belfort, and Vinit B. Mahajan, “Retinal and choroidal angiogenesis: a review of new targets,” International Journal of Retina and Vitreous, vol. 3, no. 1, 2017. View at Publisher · View at Google Scholar
  • Sheldon Rowan, Eloy Bejarano, and Allen Taylor, “Mechanistic targeting of advanced glycation end-products in age-related diseases,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018. View at Publisher · View at Google Scholar
  • Juliana Nicolau Aranha Carvalho, Carla Andreia Abreu, Julia Rios Carvalho, Ana Maria Blanco Martinez, Henrique Rocha Mendonça, Domethila Mariano de Souza Aguiar dos Santos, Suelen Adriani Marques, and Karin da Costa Calaza, “Lack of Galectin-3 attenuates neuroinflammation and protects the retina and optic nerve of diabetic mice,” Brain Research, vol. 1700, pp. 126–137, 2018. View at Publisher · View at Google Scholar
  • Simon Nusinovici, Charumathi Sabanayagam, Boon Wee Teo, Gavin Siew Wei Tan, and Tien Yin Wong, “Vision Impairment in CKD Patients: Epidemiology, Mechanisms, Differential Diagnoses, and Prevention,” American Journal of Kidney Diseases, 2019. View at Publisher · View at Google Scholar
  • Wisit Kaewput, Charat Thongprayoon, Ram Rangsin, Prajej Ruangkanchanasetr, Michael A Mao, and Wisit Cheungpasitporn, “Associations of renal function with diabetic retinopathy and visual impairment in type 2 diabetes: A multicenter nationwide cross-sectional study,” World Journal of Nephrology, vol. 8, no. 2, pp. 33–43, 2019. View at Publisher · View at Google Scholar